erythromycin ethylsuccinate

Generic: erythromycin ethylsuccinate

Labeler: wilshire pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name erythromycin ethylsuccinate
Generic Name erythromycin ethylsuccinate
Labeler wilshire pharmaceuticals
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

erythromycin ethylsuccinate 200 mg/5mL

Manufacturer
Wilshire Pharmaceuticals

Identifiers & Regulatory

Product NDC 52536-132
Product ID 52536-132_240e9111-2531-403a-bbd3-161d87185b1e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA050207
Listing Expiration 2026-12-31
Marketing Start 2020-08-24

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] macrolide antimicrobial [epc] macrolide [epc] macrolides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 52536132
Hyphenated Format 52536-132

Supplemental Identifiers

RxCUI
686400 686418
UPC
0300746305132 0352536132138
UNII
1014KSJ86F

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name erythromycin ethylsuccinate (source: ndc)
Generic Name erythromycin ethylsuccinate (source: ndc)
Application Number NDA050207 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/5mL
source: ndc
Packaging
  • 100 mL in 1 BOTTLE (52536-132-13)
source: ndc

Packages (1)

52536-132-13 100 mL in 1 BOTTLE (52536-132-13)

Ingredients (1)

erythromycin ethylsuccinate (200 mg/5mL)

Linked Drug Pages (1)

ERYTHROMYCIN ETHYLSUCCINATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "240e9111-2531-403a-bbd3-161d87185b1e", "openfda": {"upc": ["0300746305132", "0352536132138"], "unii": ["1014KSJ86F"], "rxcui": ["686400", "686418"], "spl_set_id": ["86d6353c-2b58-4219-b31d-fb5b97789094"], "manufacturer_name": ["Wilshire Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (52536-132-13)", "package_ndc": "52536-132-13", "marketing_start_date": "20200824"}], "brand_name": "ERYTHROMYCIN ETHYLSUCCINATE", "product_id": "52536-132_240e9111-2531-403a-bbd3-161d87185b1e", "dosage_form": "SUSPENSION", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "52536-132", "generic_name": "Erythromycin Ethylsuccinate", "labeler_name": "Wilshire Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ERYTHROMYCIN ETHYLSUCCINATE", "active_ingredients": [{"name": "ERYTHROMYCIN ETHYLSUCCINATE", "strength": "200 mg/5mL"}], "application_number": "NDA050207", "marketing_category": "NDA", "marketing_start_date": "20200824", "listing_expiration_date": "20261231"}